Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Rheumatology|October 23, 2013
Work disability in Finnish patients with rheumatoid arthritis: a 15-year follow-upTarja Tiippana-Kinnunen, Leena Paimela, Ritva Peltomaa, et al.
Acta Radiologica Open|May 20, 2020
Radiographic scoring systems for psoriatic arthritis are insufficient for psoriatic arthritis mutilans: results from the Nordic PAM StudyLeena Laasonen, Ulla Lindqvist, Lars Iversen, et al.
Frontiers in Medicine|February 22, 2021
Comorbidities in a Cohort of 66 Patients With Psoriatic Arthritis Mutilans-Results From the Nordic PAM StudyJosephine Mistegård, Bjorn Gudbjornsson, Ulla Lindqvist, et al.
European Journal of Endocrinology|May 2, 2003
Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritisHeikki Valleala, Jami Mandelin, Leena Laasonen, et al.
Acta Radiologica Open|September 9, 2015
Radiographic development during three decades in a patient with psoriatic arthritis mutilansLeena Laasonen, Björn Gudbjornsson, Leif Ejstrup, et al.
The Journal of Rheumatology|March 1, 2003
Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of diseaseHeikki Valleala, Leena Laasonen, Marja-Kaisa Koivula, et al.
Clinical and Experimental Rheumatology|September 8, 2020
HLA-B*27 is significantly enriched in Nordic patients with psoriatic arthritis mutilansPernilla Nikamo, Bjorn Gudbjornsson, Leena Laasonen, et al.
Clinical and Experimental Rheumatology|September 9, 2016
Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trialsAdrian Levitsky, Marius C Wick, Timo Möttönen, et al.
Arthritis and Rheumatism|July 13, 2004
Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo studyMarkku Korpela, Leena Laasonen, Pekka Hannonen, et al.
The Journal of Rheumatology|December 22, 2006
Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritisHeidi Mäkinen, Hannu Kautiainen, Pekka Hannonen, et al.
Pageof 4